 |
|
|
|
|
|
|
|
|
| Flinn Foundation 2001 Annual Report |
|
 |
|
| New Directions Defined | Page 1 of 4 | 1 | 2 | 3 | 4 | Next > |
|
|
 |
|
| |
The character of the nation's economy is changing at a dramatic pace as technology
increasingly fuels economic growth. As recently as 20 years ago, the primary factors
driving a vibrant economy were natural resources, such as land, water and minerals,
and an abundant supply of low-cost labor.
|
|
|
|
|
|
|
|
|
|
 |
For a state to fully participate in this future, it must harness and leverage existing resources, build greater collaboration among public- and private-sector institutions, act in an entrepreneurial manner, and have the patience to stay the course for a decade or more before achieving a true biosciences base.
|
 |
|
|
|
| |
Arizona took a major step forward in these rapidly expanding disciplines this year
by forming the Translational Genomics Research Institute (TGen), a tri-university
biomedical research collaborative, and persuading the nonprofit cancer-tissue
analysis group, the International Genomics Consortium (IGC), to locate its operations here. That effort brought together an unprecedented coalition of university, state, city, county, healthcare, medical research, and business leaders that raised over $90 million in just months.
This Foundation assisted in building and convening this coalition, and committed $15 million - 10 times larger than any previous single grant in our 37-year history - toward the start-up costs of TGen. Our grant funds also supported the pilot phase of the IGC's cancer-tissue research efforts. These commitments are in keeping with plans announced last year to devote all of the Foundation's healthcare grants budget for the next 10 years to increasing the competitiveness of Arizona's biomedical research enterprise.
Important as these steps are, they are just a beginning.
|
|
|
| |
| New Directions Defined | Page 1 of 4 | 1 | 2 | 3 | 4 | Next > |
|
|
|
|
|
In today's emerging markets, comparative advantage is gained by accessing and controlling knowledge-intensive discoveries that produce next-generation products, especially in the biosciences - the fastest growing segment of the economy.
